Full Length Research Paper
References
|
Aucouturier J, Dupuis L, Ganne V (2001). Adjuvants designed for veterinary and human vaccines. Vaccine 19:2666-2672. |
|
|
Canales M, Enriquez A, Ramos E, Cabrera D, Dandie H, Soto A, Falcon V, Rodriguez M, de la Fuente J (1997) Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick. Vaccine 15(4):414-422. |
|
|
Carter JM (1994). Techniques for Conjugation of Synthetic Peptides to Carrier Molecules. In: Dunn BM, Pennington MW (eds) Peptide Analysis Protocols. Humana Press, Totowa, NJ, pp. 155-191. |
|
|
Garcia-Garcia JC, Soto A, Nigro F, Mazza M, Joglar M, Hechevarria M, Lamberti J, de la Fuente J (1998). Adjuvant and immunostimulating properties of the recombinant Bm86 protein expressed in Pichia pastoris. Vaccine 16(9-10):1053-1055. |
|
|
Gil FI, Brun A, Wigdorovitz ARC, Martínez-Torrecuadrada JL, Casal I, Salinas J, Borca MV, Escribano JM (2001). High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Letters 488(1-2):13-17. |
|
|
Guerrero FD, Miller RJ, Pérez de León AA (2012). Cattle tick vaccines: Many candidate antigens, but will a commercially viable product emerge? International Journal for Parasitology 42(5):421-427. |
|
|
Guide for the Care and Use of Laboratory Animals (2011). Eighth Edition. The National Academies Press, |
|
|
Heegaard PMH, Dedieu L, Johnson N, Le Potier M-F, Mockey M, Mutinelli F, Vahlenkamp T, Vascellari M, Sørensen NS (2011). Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Archives of Virology 156(2):183-202. |
|
|
Hendrick MJ, Goldschmidt MH, Shofer FS, Wang Y-Y, Somlyo AP (1992). Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Research 52:5391-5394. |
|
|
Hilleman MR (2000). Vaccines in historic evolution and perspective: a narrative of vaccine discoveries. Vaccine 18:1436-1447. |
|
|
Jackson D, Fitzmaurice C, Brown L, Zeng W (2000). Preparation and properties of totally synthetic immunogens. Vaccine 18:355-361. |
|
|
Jahouh F, Hou S-j, KováÄ P, Banoub JH (2012). Determination of glycation sites by tandem mass spectrometry in a synthetic lactose-bovine serum albumin conjugate, a vaccine model prepared by dialkyl squarate chemistry. Rapid Communications in Mass Spectrometry 26(7):749-758. |
|
|
Kahn CM, Line S, Merck, Co (2010). The Merck veterinary manual. Whitehouse Station, N.J. : Merck & Co., |
|
|
Kurella S, Manocha M, Sabhnani L, Thomas B, Rao DN (2000). New age adjuvants and delivery systems for subunit vaccines. Indian Journal of Clinical Biochemistry 15(Suppl):83-100. |
|
|
Langeveld JP, Casal JI, Osterhaus AD, Cortes E, de Swart R, Vela C, Dalsgaard K, Puijk WC, Schaaper WM, Meloen RH (1994). First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs. Journal of Virology 68(7):4506-4513. |
|
|
Langeveld JPM, Casal I, Cortés J, Van de Wetering E, Boshuizen G, Schaaper RS, Dalsgaard WMM, Meloen KHR (1994). Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12(15):1473-1480. |
|
|
Leroux-Roels G (2010). Unmet needs in modern vaccinology: adjuvants to improve the immune response Vaccine 28(Suppl 3):C25-36. |
|
|
Rodríguez-Mallon A, Bechara GH, Zacarias RM, Benavides-Ortiz E, Soto-Rivas JL, Gómez-Ramírez AP, Jaimes-Olaya JA, Estrada-García MP (2013). Inhibition of Ehrlichia canis and Babesia canis transmission among ticks fed together on dogs vaccinated with Bm86 antigen. Open Journal of Animal Sciences 3(3A):24-32. |
|
|
Rodríguez-Mallon A, Fernández E, Encinosa PE, Bello Y, Méndez-Pérez L, Cepero L, Pérez D, González M, Garay H, Reyes O, Méndez L, Estrada MP (2012). A novel tick antigen shows high vaccine efficacy against the dog tick, Rhipicephalus sanguineus. Vaccine 30:1782-1789 |
|
|
Rodríguez-Mallon A, Gonzalez LJ, Encinosa Guzman PE, Bechara GH, Sanches GS, Pousa S, Cabrera G, Cabrales A, Garay H, Mejias R, Lopez Alvarez JR, Bello Soto Y, Almeida F, Guirola O, Rodriguez Fernandez R, Fuentes Castillo A, Mendez L, Jimenez S, Licea-Navarro A, Portela M, Duran R, Estrada MP (2020). Functional and mass spectrometric evaluation of an anti-tick antigen based on the P0 peptide conjugated to Bm86 protein. Pathogens 9(6). |
|
|
Simerska P, Ziora Z, Fagan V, Goodwin D, Edrous F, Toth I (2013). Design, synthesis and characterisation of mannosylated ovalbumin lipid core peptide self-adjuvanting vaccine delivery system. Drug Delivery and Translational Research pp. 1-10. |
|
|
Vascellari M, Melchiotti E, Bozza MA, Mutinelli F (2003). Fibrosarcomas at presumed sites of injection in dogs: characteristics and comparison with non-vaccination site fibrosarcomas and feline post-vaccinal fibrosarcomas. Journal of Veterinary Medicine Series A 50:286-291. |
|
|
Verdier F, Burnett R, Michelet-Habchi C, Moretto P, Fievet-Groyne F, Sauzeat E (2005). Aluminium assay and aluminium containing vaccines in the Cynomolgus monkey. Vaccine 23(11):1359-1367. |
|
|
Willadsen P (2008). Anti-tick vaccines.Ticks: Biology, Disease and Control. Cambridge University Press Cambridge pp. 424-446. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
